DKCM
EW icon

Davidson Kempner Capital Management’s Edwards Lifesciences EW Stock Holding History

Davidson Kempner Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Buy
+32,600
New +$2.69M 0.04% 163
2017
Q1 		– Sell
-187,500
Closed -$5.86M – 171
2016
Q4 		$5.86M Buy
+187,500
New +$6.08M 0.12% 120

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Davidson Kempner Capital Management's EW Position: Q1 2026 in Review

Davidson Kempner Capital Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 32,600 shares worth $2.61M. The stake represents 0.04% of the portfolio and ranks #163 among its holdings. This is a return to the name: Davidson Kempner Capital Management previously reported a position in EW as recently as Q4 2016.

Davidson Kempner Capital Management first reported a position in EW in Q4 2016 and has held it in 2 quarters since. The position peaked at $5.86M in Q4 2016. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Davidson Kempner Capital Management held 32,600 shares of Edwards Lifesciences worth $2.61M as of Q1 2026.
  • Edwards Lifesciences was a new Davidson Kempner Capital Management position in Q1 2026.
  • Edwards Lifesciences made up 0.04% of Davidson Kempner Capital Management's portfolio in Q1 2026, its #163 holding.
  • Davidson Kempner Capital Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 2 quarters since.
  • Davidson Kempner Capital Management's Edwards Lifesciences position peaked at $5.86M in Q4 2016.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2026, filed 15 May 2026.